Article Details

LAVA Therapeutics to Present its Bispecific Gamma Delta T Cell Engagers for Treatment of ...

Retrieved on: 2021-10-07 15:22:30

Tags for this article:

Click the tags to see associated articles and topics

LAVA Therapeutics to Present its Bispecific Gamma Delta T Cell Engagers for Treatment of .... View article details on hiswai:

Excerpt

The corrected release follows: LAVA Therapeutics N.V. (Nasdaq: LVTX), a clinical-stage biotechnology company focused on developing bispecific gamma delta T cell ...

Article found on: finance.yahoo.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up